HT942523C0005
Definitive Contract
Overview
Government Description
AWARD OF R&D DHA PHASE II SBIR TO TECHNOLOGY HOLDING FOR PROJECT TITLED DEVELOPMENT OF HUMAN MONOCLONAL ANTIBODY THERAPEUTIC AGAINST KLEBSIELLA PNEUMONIAE INFECTION
Awardee
Awarding Agency
Place of Performance
West Valley City, UT 84119 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Est. Average FTE
3
Related Opportunity
HQ003420RBDST
Technology Holding was awarded
Definitive Contract HT942523C0005 (HT9425-23-C-0005)
worth up to $1,099,026
by Army Medical Research and Development Command
in February 2023.
The contract
has a duration of 2 years 5 months and
was awarded
through SBIR Topic Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection
with a Small Business Total set aside
with
NAICS 541715 and
PSC AN12
via direct negotiation acquisition procedures with 1 bid received.
SBIR Details
Research Type
Small Technology Transfer Research Program (STTR) Phase II
Title
Development of Human Monoclonal Antibody Therapeutic Against Klebsiella pneumoniae Infection
Related Solicitation
Abstract
Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising drug class that could be applied to antibiotic resistant infections to harness a patients own immune system to effectively combat the invading threat. In this program we continue program development to determine binding epitopes of novel antibody candidates, express candidates, and show infectivity reduction potential in in vitro and in vivo assays.
Research Objective
The goal of phase II is to continue the R&D efforts initiated in Phase I. Funding is based on the results achieved in Phase I and the scientific and technical merit and commercial potential of the project proposed in Phase II. STTRs are completed in conjunction with a research institution.
Topic Code
DHA202-003
Agency Tracking Number
H2-0726
Solicitation Number
20.2
Contact
Mukund Karanjikar
Status
(Complete)
Last Modified 5/2/25
Period of Performance
2/27/23
Start Date
7/26/25
Current End Date
7/26/25
Potential End Date
Obligations
$1.1M
Total Obligated
$1.1M
Current Award
$1.1M
Potential Award
Award Hierarchy
Definitive Contract
HT942523C0005
Subcontracts
Activity Timeline
People
Suggested agency contacts for HT942523C0005
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
None
IT Commercial Item Category
Not Applicable
Awardee UEI
U52NGYKN42H6
Awardee CAGE
5CTM1
Agency Detail
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
W23RYX
Created By
jeanne.n.medina.civ.ht9425@health.mil
Last Modified By
john.lee@sup97dh
Approved By
jennifer.m.mcmurry.civ.ht9425@health.mil
Legislative
Legislative Mandates
None Applicable
Performance District
UT-02
Senators
Mike Lee
Mitt Romney
Mitt Romney
Representative
Chris Stewart
Modified: 5/2/25